We are live on
!
Find out more
WPW
Winthrop Partners - WNY Portfolio holdings
AUM
$202M
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$7.31M
(+6%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
8.83%
Top 10 Holdings %
Top 10 Hldgs %
25.59%
Holding
439
New
314
Increased
38
Reduced
20
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$619K |
| 2 |
Regions Financial
RF
|
+$380K |
| 3 |
NextEra Energy
NEE
|
+$342K |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$231K |
| 5 |
Biogen
BIIB
|
+$202K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.18M |
| 2 |
John Wiley & Sons Class A
WLY
|
+$310K |
| 3 |
Williams-Sonoma
WSM
|
+$237K |
| 4 |
BOK Financial
BOKF
|
+$225K |
| 5 |
Procter & Gamble
PG
|
+$88.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.47% |
| 2 | Consumer Staples | 13.14% |
| 3 | Healthcare | 11.09% |
| 4 | Technology | 9.83% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Edwards Lifesciences
EW
$50B
| $44K | 0.03% |
+960
| New | +$41.7K |
|
177
Phillips 66
PSX
$84.4B
| $43.9K | 0.03% |
+449
| New | +$43.7K |
|
178
State Street
STT
$50.2B
| $43.5K | 0.03% |
+443
| New | +$46.4K |
|
|
MRSH
179
Marsh
MRSH
$91.4B
| $43.2K | 0.03% |
+536
| New | +$44.4K |
|
180
WesBanco
WSBC
$3.99B
| $42.2K | 0.03% |
+1,000
| New | +$42.2K |
|
181
Xylem
XYL
$27.3B
| $41.6K | 0.03% |
+550
| New | +$40.7K |
|
182
Cullen/Frost Bankers
CFR
$10.3B
| $41.4K | 0.03% |
+396
| New | +$41.4K |
|
183
Occidental Petroleum
OXY
$55.6B
| $39.6K | 0.03% |
+575
| New | +$40.2K |
|
184
CSX Corp
CSX
$93B
| $39.2K | 0.03% |
+2,160
| New | +$40.4K |
|
185
Avnet
AVT
$7.12B
| $38.3K | 0.03% |
+938
| New | +$39.7K |
|
186
NatWest
NWG
$73.7B
| $37.3K | 0.03% |
+4,643
| New | +$39K |
|
187
iShares Global Materials ETF
MXI
$346M
| $36.9K | 0.03% |
+550
| New | +$39K |
|
|
APC
188
DELISTED
Anadarko Petroleum
APC
| $35.9K | 0.03% |
+600
| New | +$35.2K |
|
189
Essential Utilities
WTRG
$11.4B
| $33.8K | 0.03% |
+1,000
| New | +$34.8K |
|
190
Astronics
ATRO
$3.38B
| $32.2K | 0.02% |
+1,277
| New | +$38.1K |
|
191
Marriott International
MAR
$99B
| $32.2K | 0.02% |
+246
| New | +$34.5K |
|
192
WisdomTree Enhanced Commodity Strategy Fund
GCC
$270M
| $31.9K | 0.02% |
+1,647
| New | +$31.9K |
|
|
PARA
193
DELISTED
Paramount Global Class B
PARA
| $31.6K | 0.02% |
+597
| New | +$32.8K |
|
194
Entergy
ETR
$50.4B
| $31K | 0.02% |
+786
| New | +$30.4K |
|
195
Expeditors International
EXPD
$21.8B
| $30.8K | 0.02% |
+500
| New | +$32.1K |
|
196
Nucor
NUE
$58.5B
| $30.3K | 0.02% |
+500
| New | +$33.1K |
|
197
Aegon
AEG
$14B
| $29.8K | 0.02% |
+5,372
| New | +$29.6K |
|
198
MDU Resources
MDU
$4.17B
| $28.1K | 0.02% |
+2,661
| New | +$27K |
|
|
RDS.B
199
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $27.3K | 0.02% |
+400
| New | +$26.9K |
|
200
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
| $26.9K | 0.02% |
+200
| New | +$28K |
|
Similar funds
TI
BFA
PCMK
AFWM
PCM
IFU
MFG
RA
Winthrop Partners - WNY's Q1 2018 Portfolio in Review
As of Q1 2018, Winthrop Partners - WNY held 439 positions worth $130M, up 6% from $123M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Winthrop Partners - WNY deployed $11.5M of net new capital in Q1 2018, opening 314 new positions and adding to 38 existing holdings. Its largest new stake was Regions Financial: 20,080 shares worth $369K.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $2.18M trimmed.
- Winthrop Partners - WNY's largest Q1 2018 buy was Regions Financial: 20,080 shares worth $369K.
- Winthrop Partners - WNY added most to Vanguard Morningstar Small-Cap ETF in Q1 2018, an estimated $619K increase.
- Winthrop Partners - WNY's biggest Q1 2018 reduction was Pfizer, cutting an estimated $2.18M.
- Winthrop Partners - WNY's ten largest holdings make up 26% of its $130M portfolio in Q1 2018.
- Winthrop Partners - WNY opened 314 new positions and closed 0 in Q1 2018.
- Winthrop Partners - WNY's portfolio value rose 6% quarter-over-quarter to $130M.
Based on Winthrop Partners - WNY's 13F filing for Q1 2018, filed 13 Jun 2018.